Exposure to ARVs and Infant Development
Exposure to antiretroviral medicines during the perinatal period continues to raise questions as to the long-term effects on those exposed infants. HIV-negative but exposed infants ages 9-15 months were assessed for cognitive development, including language and motor skills. Researchers concluded that perinatal ARV use is safe and has little effect on cognitive development infants but continued study is warranted.
Citation:
Sirios PA, Huo Y, Williams PL, Malee K, Garvie PA, Kammerer B, Rich K, Van Dyke RB, Nozyce ML; Pediatric HIV/AIDS Cohort Study. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.
Original Article (subscription may be required)
